BioTime to form Asian subsidiary for stem cell products
BioTime, Inc will organize a new subsidiary, BioTime Asia, Limited, for the purpose of clinically developing and marketing therapeutic stem cell products in the People’s Republic of China, and marketing stem cell research products in China and other countries in Asia. BioTime Asia will initially seek to develop the therapeutic products for the treatment of ophthalmologic, skin, musculo-skeletal …
[Read the full article here]Related News:
Biotime's new subsidiary to focus on clinical development and marketing therapeutic stem cell products in China
BioTime Sets Up Subsidiary in China to Develop Stem Cell Therapeutics
BioTime Opens Asian Subsidiary to Sell Stem Cell Tools, Therapies